Paion AG
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation… Read more
Paion AG (PAIOF) - Total Assets
Latest total assets as of June 2023: $32.24 Million USD
Based on the latest financial reports, Paion AG (PAIOF) holds total assets worth $32.24 Million USD as of June 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Paion AG - Total Assets Trend (2003–2022)
This chart illustrates how Paion AG’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Paion AG - Asset Composition Analysis
Current Asset Composition (December 2022)
Paion AG's total assets of $32.24 Million consist of 46.7% current assets and 53.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 27.8% |
| Accounts Receivable | $2.23 Million | 5.8% |
| Inventory | $3.72 Million | 9.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $19.59 Million | 51.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2003–2022)
This chart illustrates how Paion AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Paion AG's current assets represent 46.7% of total assets in 2022, a decrease from 87.1% in 2003.
- Cash Position: Cash and equivalents constituted 27.8% of total assets in 2022, down from 84.5% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 51.0% of total assets, an increase from 7.0% in 2003.
- Asset Diversification: The largest asset category is intangible assets at 51.3% of total assets.
Paion AG Competitors by Total Assets
Key competitors of Paion AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Paion AG - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Paion AG generates 0.87x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Paion AG is currently not profitable relative to its asset base.
Paion AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.76 | 2.58 | 4.01 |
| Quick Ratio | 0.51 | 2.15 | 4.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.99 Million | $ 15.41 Million | $ 21.76 Million |
Paion AG - Advanced Valuation Insights
This section examines the relationship between Paion AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.64 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.8% |
| Total Assets | $38.18 Million |
| Market Capitalization | $129.70K USD |
Valuation Analysis
Below Book Valuation: The market values Paion AG's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Paion AG's assets grew by 3.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Paion AG (2003–2022)
The table below shows the annual total assets of Paion AG from 2003 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $38.18 Million | +3.79% |
| 2021-12-31 | $36.78 Million | +30.67% |
| 2020-12-31 | $28.15 Million | +13.00% |
| 2019-12-31 | $24.91 Million | +2.42% |
| 2018-12-31 | $24.32 Million | -23.72% |
| 2017-12-31 | $31.89 Million | -16.05% |
| 2016-12-31 | $37.98 Million | -12.62% |
| 2015-12-31 | $43.47 Million | -34.68% |
| 2014-12-31 | $66.55 Million | +269.39% |
| 2013-12-31 | $18.02 Million | -36.42% |
| 2012-12-31 | $28.34 Million | +124.78% |
| 2011-12-31 | $12.61 Million | -53.02% |
| 2010-12-31 | $26.84 Million | -24.51% |
| 2009-12-31 | $35.55 Million | -27.91% |
| 2008-12-31 | $49.31 Million | +8.28% |
| 2007-12-31 | $45.54 Million | -34.99% |
| 2006-12-31 | $70.05 Million | +5.89% |
| 2005-12-31 | $66.15 Million | +157.70% |
| 2004-12-31 | $25.67 Million | +156.63% |
| 2003-12-31 | $10.00 Million | -- |